Every time an Anopheles mosquito bites a person, it injects a cocktail of salivary proteins into the skin. The human immune ...

Blood plasma has long been the workhorse of clinical diagnostics, a fluid so rich in molecular information that a single draw ...

Children whose mothers were vaccinated against tetanus, diphtheria, and pertussis (Tdap) during pregnancy saw significantly ...

Immunovant will not pursue further development of IMVT-1402 for skin lupus after a trial missed its main goal, despite some ...

Werfen’s Aptiva APS IgA Reagent receives FDA clearance and CE mark, completing the company’s APS testing portfolio for IgA, IgG, and IgM.

Immunovant is discontinuing development of IMVT-1402 in cutaneous lupus but will continue to develop the therapy for several other autoimmune diseases.

Immunovant has stopped development of IMVT-1402 in cutaneous lupus erythematosus after failing a midphase test, closing off ...

Antibody expression: Tsingke works with multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with ...

Tsingke today announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed ...

Hansa Biopharma AB (publ), "Hansa" (Nasdaq Stockholm: HNSA), has today on September 22, 2026 held its Extraordinary General Meeting. The Extraordinary General Meeting was held by physical presence of ...

Tsingke today announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large ...

New research to prevent FNAIT is focused on the potential of HPA-1a-targeted antibody prophylaxis during pregnancy.